MedPath

Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers

Completed
Conditions
Quality of Health Care
Patient Care Team
Decision Making
Neoplasms/Therapy
Registration Number
NCT04000802
Lead Sponsor
Moroccan Society of Surgery
Brief Summary

Nowadays, the recommended approach for decision-making for oncology patients is based on multidisciplinary meetings (MDT). However, the quality of decision-making during MDT depends on other factors such as the quality of presentation of clinical cases, the degree of participation of different specialists.

In this study, the investigators will evaluate the decision-making during digestive oncology MDT using the validated "Metric Of Decision-Making" tool (MDT-MODe), in the national institute of oncology (Rabat, Morocco).

Detailed Description

Multidisciplinary cancer meetings are a multidisciplinary discussion and decision-making process for a patient with cancer. It allows a sharing of knowledge and decision-making, taking into account the opinion of all the specialists involved in the treatment of cancer, in order to propose the best possible decision for the patient. Nevertheless, the quality of decision-making during CPR depends on other factors such as the quality of presentation of clinical cases, the degree of participation of different specialists and the dynamics of meetings.

There are several validated tools for the quantitative assessment of the decision-making mode during CPRs. The best known is the Metric Of Decision-Making (MDT-MODe). MDT-MODe is a validated tool for the observational evaluation of teamwork and the quality of decision-making during cancer CPR.

MDT-MODe is designed to encourage teams to make holistic decisions tailored to each patient and allows an observer to assess, on a case-by-case basis, in a quantitative and objective way:

The quality of the clinical information (antecedents, radiological pathologies, pathological, comorbid, psychosocial problems and patients' points of view) Contribution to decision-making in teams of key professional groups (surgeons, physicians, oncologists, nurses, health professionals, radiologists, pathologists) Taken together, these notes provide an indication of the quality of team decision-making.

In this study, the investigators will evaluate the decision-making during digestive oncology MDT using the validated "Metric Of Decision-Making" tool (MDT-MODe), in the national institute of oncology (Rabat, Morocco).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • All consecutive cases presented during multidisciplinary cancer meeting for digestive cancer.
Exclusion Criteria
  • Cases not registered in the electronic health record system.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MODE-MDT scores60 days from the multidisciplinary team meeting

The scores of the Metric Of Decision-Making tool during multidisciplinary team meeting for digestive cancer. The instrument include 10 questions rated from 1 to 5. Higher scores indicate better results. The instrument include questions about the quality of clinical information (History, radiological, pathological, comorbid health conditions, psychosocial issues, and patients' views) and the contribution to team decision making of key professional groups (Surgeons, physicians, oncologists, nurses, allied healthcare professionals, radiologists, pathologists and MDT coordinators) ans a question about the decision (Clear, deferred, no decision. Each question is analyzed separately (mean, median, standard deviation, quartiles).

Secondary Outcome Measures
NameTimeMethod
Decision reached60 days from the multidisciplinary team meeting

The rate of cases with decisions during multidisciplinary team meetings (Clear decision about treatment in the MODE-MDT instrument).

Decision factors60 days from the multidisciplinary team meeting

Predictive factors for reaching a clear decision about treatment during multidisciplinary team meetings. The factors analyzed are the question of the MODE-MDT instrument.

Trial Locations

Locations (1)

National Institut of oncology

🇲🇦

Rabat, Morocco

© Copyright 2025. All Rights Reserved by MedPath